HCV Mosaic-A

Hepatitis C Virus Mosaic Antigen-A Recombinant

HCV Mosaic-A protein contains a short core peptide residue 1-50a.a., 1269-1316a.a. of NS3, three epitopes from NS4 and two epitopes from NS5 and the genotype of all sequences are 1b.
A specific peptide was identified from each region; the four peptides from each region were linked together and expressed in E .coli. The recombinant protein migrates at 33kDa.
Shipped with Ice Packs
Cat. No.
BT13130
Source
Escherichia Coli.
Appearance
Sterile Filtered clear solution.

HCV Mosaic-B

Hepatitis C Virus Mosaic Antigen-B Recombinant

HCV Mosaic-B protein contains a long core peptide residues 1-120a.a., 1192-1415a.a. of NS3, three epitopes from NS4 and two epitopes from NS5 and the genotype of all sequences are 1b.
A specific peptide was identified from each region; the four peptides from each region were linked together and expressed in E .coli. The recombinant protein migrates at 65kDa.
Shipped with Ice Packs
Cat. No.
BT13223
Source
Escherichia Coli.
Appearance
Sterile Filtered clear solution.

HCV NS3

Hepatitis C Virus NS3 (1450-1643 a.a.) Recombinant

The E.coli derived 22kDa recombinant protein contains the HCV NS3 genotype 1b immunodominant regions, amino acids 1450-1643. The protein is fused with b-galactosidase (114 kDa) at N-terminus, pI 5.43.
Shipped with Ice Packs
Cat. No.
BT13292
Source
Appearance

HCV NS3 (1192-1459 a.a.)

Hepatitis C Virus NS3 Genotype-1b, (1192-1459 a.a.) Recombinant

The E.coli derived recombinant protein contains the HCV NS3 immunodominant regions, amino acids 1192-1459. The protein is fused to a GST tag at N-Terminus.
Shipped with Ice Packs
Cat. No.
BT13386
Source
Appearance

HCV NS5 Genotype-6a

Hepatitis C Virus NS5 Genotype-6a Recombinant

The E.coli derived recombinant protein contains the HCV NS5 Genotype 6a immunodominant regions, amino acids 2212-2313. The protein is fused with GST tag N-terminus.
Shipped with Ice Packs
Cat. No.
BT17442
Source
Appearance

HCV NS5, Biotin

Hepatitis C Virus NS5, Biotin Recombinant

The E.coli derived Biotin Labeled recombinant protein contains the HCV NS5 immunodominant regions. HCV NS5 antigen (recombinant) a.a 2061 to a.a 2302 of HCV polyprotein. The protein is fused to a GST tag at N-terminus.
Shipped with Ice Packs
Cat. No.
BT17516
Source
Appearance

HCV NS5, HRP

Hepatitis C Virus NS5, Horseradish Peroxidase Recombinant

The E.coli derived Biotin Labeled recombinant protein contains the HCV NS5 immunodominant regions.
Shipped with Ice Packs
Cat. No.
BT17589
Source
Appearance

HCV NS5A

Hepatitis C Virus NS5A Recombinant

Recombinant HCV NS5A produced in E. coli is a single polypeptide chain containing 118 amino acids (aa 2210-2306) and having a molecular mass of 13.4kDa.
Recombinant HCV NS5A is fused to a 21 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT17665
Source
Escherichia Coli.
Appearance
Sterile filtered colorless solution.

HCV NS5B

Hepatitis C Virus NS5B Recombinant

The E.coli derived recombinant protein contains the full length of the NS5B immunodominant regions Genotype 1B and fused to a 6xHis tag at C-Terminus.
Shipped with Ice Packs
Cat. No.
BT17707
Source
Appearance

HCV NS5B (2634-2752 a.a)

Hepatitis C Virus NS5B (2634-2752 a.a) Recombinant

Recombinant Hepatitis C Virus NS5B produced in E. coli is a single polypeptide chain containing 155 amino acids (aa 2634-2752) and having a molecular mass of 17kDa (NCBI Accession # NP_671491).
Recombinant HCV NS5B is fused to a 36 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT17805
Source
Escherichia Coli.
Appearance
Sterile filtered colorless solution.
Definition and Classification

Hepatitis C is a liver disease caused by the hepatitis C virus (HCV), a small, enveloped, positive-sense single-stranded RNA virus belonging to the genus Hepacivirus within the family Flaviviridae . HCV can cause both acute and chronic hepatitis, ranging from a mild illness lasting a few weeks to a serious, lifelong illness including liver cirrhosis and cancer . There are seven major genotypes and numerous subtypes of HCV, which vary in their geographical distribution and response to treatment .

Biological Properties

HCV particles are spherical and range from 40 to 80 nanometers in diameter . The virus has a lipid membrane envelope embedded with two glycoproteins, E1 and E2, which play crucial roles in viral attachment and entry into host cells . HCV primarily infects hepatocytes in the liver but can also be found in other tissues such as lymph nodes and peripheral blood mononuclear cells . The virus exhibits significant genetic diversity, which contributes to its ability to evade the host immune system .

Biological Functions

HCV’s primary function is to replicate within host cells. It hijacks the host’s cellular machinery to produce viral proteins and RNA . The virus plays a role in immune evasion by interfering with the host’s immune responses, including the inhibition of interferon signaling pathways . HCV also induces chronic inflammation, which can lead to liver fibrosis, cirrhosis, and hepatocellular carcinoma .

Modes of Action

HCV enters host cells through interactions with several receptors, including the low-density lipoprotein receptor (LDLr), heparan sulfate proteoglycans (HSPGs), scavenger receptor B1 (SRB1), and CD81 . Once inside the cell, the virus releases its RNA genome, which is translated into a single polyprotein. This polyprotein is then cleaved into structural and non-structural proteins that are essential for viral replication . The virus also manipulates host cell signaling pathways to create a favorable environment for its replication .

Regulatory Mechanisms

The expression and activity of HCV are regulated at multiple levels. Transcriptional regulation involves the interaction of viral RNA with host cell factors that enhance or inhibit viral replication . Post-translational modifications, such as phosphorylation and ubiquitination, also play critical roles in regulating the stability and function of viral proteins . Additionally, HCV can modulate host immune responses to promote viral persistence .

Applications in Biomedical Research

HCV research has led to significant advancements in understanding viral pathogenesis and developing therapeutic strategies. Direct-acting antivirals (DAAs) have revolutionized HCV treatment, offering high cure rates with fewer side effects compared to previous therapies . HCV is also used as a model to study RNA virus replication and host-virus interactions . Diagnostic tools, such as serological assays and nucleic acid tests, are essential for detecting HCV infection and monitoring treatment response .

Role in the Life Cycle

HCV’s life cycle begins with the attachment of the virus to host cell receptors, followed by entry into the cell via endocytosis . Once inside, the viral RNA is released and translated into a polyprotein, which is processed into functional viral proteins . These proteins facilitate viral RNA replication and assembly of new virions, which are then released to infect other cells . Throughout its life cycle, HCV interacts with various host factors to ensure its replication and persistence .

© Copyright 2024 Thebiotek. All Rights Reserved.